home / stock / bnr / bnr news

BNR News and Press, Burning Rock Biotech Limited From 07/08/22

Stock Information
Company Name: Burning Rock Biotech Limited
Stock Symbol: BNR
Market: NASDAQ
Website: brbiotech.com
Menu
BNR BNR Quote BNR Short BNR News BNR Articles BNR Message Board
Get BNR Alerts

News, Short Squeeze, Breakout and More Instantly...
BNR - ARWR, TRIP and CARA among after hour movers

Gainers: Burning Rock Biotech ( BNR ) +4% . TripAdvisor  ( TRIP ) +2% . comScore ( SCOR ) +2% . Arrowhead Pharmaceuticals ( ARWR ) +2% . Bolt Biotherapeutics ( BOLT ) +2% . Losers: Swvl Holdings  ( SWVL ) ...
BNR - Tracking Baillie Gifford's 13F Portfolio - Q1 2022 Update

Baillie Gifford’s 13F portfolio value decreased from ~$182B to ~$143B this quarter. They increased Affirm Holdings, Coupang, and Ginkgo Bioworks while reducing Petroleo Brasileiro and First Republic Bank. The top three positions are Tesla Motors, Moderna, and Illumina, and ...

BNR - Burning Rock Announces the Launch of China's First Prospective Interventional Validation Study on Multi-Cancer Early Detection - the PREVENT Study

CHENGDU, China, June 30, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced ...

BNR - NeuroSense, Rapid Micro top healthcare gainers; Renalytix, Angion lead losers' pack

Gainers: NeuroSense Therapeutics ( NRSN ) +53% . Rapid Micro Biosystems ( RPID ) +36% . Burning Rock Biotech ( BNR ) +15% . Tyra Biosciences ( TYRA ) +7% . Addex Therapeutics ( ADXN ) +5% . Losers: Renalytix ( RNLX ) -40% ...
BNR - Burning Rock Announces Changes to Board Composition

GUANGZHOU, China, June 24, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announce...

BNR - Burning Rock Biotech announces $10M stock buyback plan

Burning Rock Biotech (NASDAQ:BNR) has announced a share repurchase plan to buyback Class A ordinary shares in the form of American depositary shares (ADSs) with an aggregate value of up to $10M. The repurchases will be funded from existing cash balance. The program will run for a year. BNR sh...

BNR - Burning Rock Announces US$10 Million Share Repurchase Program

GUANGZHOU, China, June 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announce...
BNR - Burning Rock Announces Plan to Pursue An Alternative Listing

GUANGZHOU, China, June 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announce...

BNR - Bone Biologics, Akero top healthcare gainers; AC Immune, Arcellx lead losers' pack

Gainers: Bone Biologics (BBLG) +13%. Akero Therapeutics AKRO +10%. Biotricity (BTCY) +9%. Jasper Therapeutics (JSPR) +7%. Burning Rock Biotech (BNR) +6%. Losers: AC Immune ACIU -17%. Arcellx ACLX -17%. SOPHiA GENETICS (SOPH) -16%. AirSculpt Te...

BNR - Burning Rock Presents Latest Clinical Data from THUNDER Study at 2022 ASCO Annual Meeting

Burning Rock Presents Latest Clinical Data from THUNDER Study at 2022 ASCO Annual Meeting PR Newswire SHANGHAI , June 15, 2022 /PRNewswire/ -- Burning Rock (NASDAQ:BNR) presented the final results from the multi-center case-control THUNDER study (THe UNin...
Previous 10 Next 10